z-logo
open-access-imgOpen Access
The Role of Treg Cells in the Cancer Immunological Response
Author(s) -
Zhi Zhang Yang,
Stephen M. Ansell
Publication year - 2009
Publication title -
american journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1558-3775
pISSN - 1553-619X
DOI - 10.3844/ajisp.2009.17.28
Subject(s) - treg cell , immunology , cancer , antibody response , biology , immune system , genetics , t cell , il 2 receptor
Problem statement: T cell-mediated immunosuppression has been observed for decades without clarification as to which factor was responsible for this observation. The identification of CD4+CD25+ regulatory T (Treg) cells represents a milestone in the filed of immunology and provides an explanation for T-cell-mediated immunosuppression. Although Treg cells were originally identified for their ability to prevent organ-specific autoimmune disease in mice, emerging evidence suggests that Treg cells play a pivotal role in tumor immunity and contribute to tumor growth and progression, thereby having an important impact on the outcome of cancer patients. Approach: This article reviewed the medical literature to describe how Treg cells affect anti-tumor immunity. Results: Treg cells suppressed anti-tumor immunity by inhibiting the effector functions of tumor-specific T cells and NK cells. Importantly, tumor cells played an active role in recruiting and generating Treg cells and creating a suppressive tumor microenvironment. Strategies to deplete Treg cells or inhibit their function had yielded promising results by enhancing anti-tumor immunity in experimental studies as well as clinical practice. Conclusion: A better understanding of the pathophysiology of Treg cells not only increased our knowledge in a variety of aspects of immunology but also potentially benefited cancer patients

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here